disney here. >> guy adami. >> i'm a big fan of the banks here but when citibank trades at 3% to 5% to tangible buy, it is a buy. that's where it is now. >> see you back here tomorrow at 5:00 for for my mission is simple, to make you money i'm here to level the playininv. there is always a bull market somewhere and i promise to help you find it. "mad money" starts now. >> i'm cramer. welcome to "mad money. welcome to cramerica my job is to beentertain, teach call me or tweet me @jimcramer

down with the tie ranrany, we ho stop worrying about the declines the yield on the ten-year got hammered before the market open so the averages got hamerred as i did my best to protest that and as treasury yields bounced back, stocks did, too. down 589 and s&p up .08% being down 2% and nasdaq up 3.8% down about 1.7% you know what i'm calling this today i'm calling a huge win for the bulls. normally when you see this wild action in bonds, yields nosedivi nosediving, it means a recession is around the corner but i think that's a misreading of the current situation. the truth is u.s. treasuries are giving a much better return than bonds from any other developed country. if you live in europe and want a nice, low-risk free return exchange euros for dollars and buy u.s. treasuries. that drives rates down

call it globalization collateral damage the russia bond buyers from overseas is spooking the stock market stock traders see it as a symptom of incredible weakness in reality, it's a symptom of weakness that strengthens the economy because long-term interest rates are fabulous for financial health the dollar is too strong but not near negative as positive. you want a mortgage? finance a new car? the rates got more intensing why does the stock market turn off and it probably will be again. because there are kinds of investors that get scared when they see interest rates moving sharply. it usually means something has gone awry there is a real possibility it's forecasting a serious economic slow down but it's also possible that we're simply seeing a demand

shock as buyers load up and investors get spooked. when i was a hedge fund manager it was hard to buy now it's like here is how i see it we know why the rest of the world's interest rates are plummeting there is not enough demand and economies are stalling, especially china that's bad news for american companies that do business over sea, i agree we don't want to slow the rest of the world just because they are having a slowdown over there, doesn't mean there is one here when you listen to the macro commentators that look at the ten-year, you think the sky is falling. over and over again they predict we will be overwhelmed by global weakness investors seek safe assets in anticipation of a recession, couple the looming financial catastrophe and less demand for money. the bond market is never wrong they say

my view? i think the bond smoke i feel the top down approach is bewildering and i'm being an ambassador of goodwill there why make judgments based on numbers? there are so many data points with companies that are accurate they fret about the ten-year can't name 100 of the names in the s&p 500. i live, eat, and breathe these stuff that's why i prefer to take a bottom's up approach. i sympathize with views to get a sense of what is going on. i think mine is better than theirs so when my bottoms up meth methodolo methodology, i checked in with j.p. morgan. the annual bus tour stopped trading. he's currently canvassing the east costa take the pulse of our economy. he's discovering credit card business booming up 8%, consumer lending is strong. charge offs meaning bad loans continue to decline. that doesn't sound like a recession to me but expansion.

overall gdp growth slowed and consumer spending has, get this, strengthened as of late. did anybody say that i checked in with them not just one company while the bank stocks plummet, all the 25 largest banks say consumer credit is strong. how about away from j.p. morgan? last week mortgage applications increased by 5.3%. refinances were up 12% that's exactly what you would expect with treasury yields plummeting that's a positive. 30-year fixed mortgage fell to the lowest level since november of 2016. i want to get one. how about you? great for housing and punches weight for economic growth does that sound like a recession? 3.7 unemployment rate. put it together and it's hard to believe we're facing a slowdown so i don't want you to panic when we see like tomorrow and coal come in and rates are 1.4%

it's probably going to happen. why do i care? let's pick a metaphor. i care because of cvs. stock up more than 7% today after a terrific quarter the game you hissmissed if you e too focused on the ten-year. cvs with 6200 stores, 300,000 people for the broader u.s. econo economy. today the company reported incredible numbers sharply better than the front of the store and pharmacy despite amazon and drug prices, cvs is doing great the company is crushing it with aetna that so many questioned. who i spoke to the ceo this afternoon, he's one of my favorite executives. he talked about a robust consumer that goes out with front of the store merchandise

and offering in-home delivery which he says millennials love whatever cvs has a ton of debt. they can potentially benefit from lower interest rates like a consumer that refinances their mortgage the cash flow is massive there is a lot to like if you listen, they can't tell c cvs from cbs the vasts of the s&p might as well be a basket of so i they think they are the same pieces of soy. they are focused like a laser. aren't you sick of the fed i'm sick of the fed. lower interest rates and lower gasoline prices should be a boom for the consumer no wonder people have more money to spent on health and beauty items. the tariffs aren't hurting cvs customers. that's one example now someone can say jim, how about disney imperfect quarter and higher recent months.

it was never about 2019. i told you it's a 2021 store bottom line, don't let the talking heads blind you to everything going right including lower interest rates sure, there is negatives here but if you keep your eyes open, if you have situational awareness, if you're like coach belichick and you get the job done and know your assignment, then when you're waiting in line at cvs and you think i should buy the stock, i think cvs' stock is worth buying at one of the greatest days in the company's history. the fact the central banks just cut interest rates, oh, wow. huh. not that negative. lower rates will help turn the economies around and making cheaper to borrow money here in the united states. i don't know, i guess it's a lose, lose if your stupid. it's a win, win, if you know what you're talking about. alex in california, alex >> caller: hey, what's going on big jim? >> you know what, alex, i'm tired of people being so darn negative i don't know about you.

>> caller: hey, i completely agree. i got a great question for you on amgen they reported a great quarter and i'm wondering what you think for the long term? >> their cancer portfolio is better than i thought six months ago. i'm not happy with the distribution of the migraine drug because they didn't get the right formula. it's got a very good balance sheet. my travel trust owns it. i would not sell it. i would be a buyer at 12 times earnings that's not buyer like buyer, mistakenly bought. drew -- stock joke drew in florida, drew? >> caller: boo-yah, jim. thanks for having me on the show and shoutout to the newest eagle j and a harris. >> i'm liking everything i heard. >> caller: can you hear me >> clear as day. >> caller: perfect so i'm fairly new to stock trading and was curious to hear your thoughts where you see

deutsche bank heading? is there reason to be optimistic given restructuring? >> no. no i mean, if you want to go down there, go by santandair. am i too emphatic? i meant to say no, i wouldn't buy it i thought it was sometimes more emp f emphatic to say no >> caller: first time long time. big market up and down boo-yah. >> i like that that's creativity. like adobe go ahead >> caller: my stock is out front media out. you had the ceo on a little while back like what i heard and did homework and bought stock. nice run 5.3% dividend i like to know what you think about them at the level they are at now. >> i like it i like them. i think that you're dead right and the numbers were really

pretty good. they were better than expected and you got a good one by the way, i did not mean to be quick to drew, because drew called in and deserves better than no. i didn't want him to speculate on a day it was down, i'm sorry, jamie, i put those two in the same sentence. i think you'll accept my apologies but we won't be dining in the hamptons together the ten-year, the ten-year, the ten-year, the ten-year is coming anyway, you keep your eyes open you realize in america, lower rates are actually positive, not negative unless we're bizarre wings victory, remember that arms on venus. we'll get those on i am tired of hearing about this defeat i'm getting examining where your money is safest and shares took a tumble after reporting a mixed quarter. i'll sit down with the ceo and get clarity like the lenses and i've got the exclusive with the

only cannabis stock that's received fda approval. it's being brought down because etfs, we'll thc this situation stick with cramer. >> announcer: don't miss a second of "mad money" foll follow @jimcramer on twitter have a question? tweet cramer #madtweets, send game an email to madmoney.cnbc.com or give us a call at 1-800-743-cnbc ss something head to madmoney.cnbc.com. your daily dashboard from fidelity. a visual sna of your inv. key portfolio events. all in one place. because when it's decision time... you need decision tech.

only from fidelity. your but as you get older,hing. it naturally begins to change, causing a lack of sharpness, or even trouble with recall. thankfully, the breakthrough in prevagen helps your brain and actually improves memory. the secret is an ingredient originally discovered... in jellyfish. in clinical trials, prevagen has been shown to improve short-term memory. prevagen. healthier brain. better life.

[ because i'm me" byfrom the 5am wakers, this is us. to the 6am sleepers. and the hope this trip never end-ers everyone uses their phone differently and in different places. that's why xfinity mobile created a different kind of wireless network one that's designed to save you money. by auto connecting to millions of secure wifi hot spots. and the best lte everywhere else. xfinity mobile. it's wireless reimagined. simple. easy. awesome.

if i hear one more colema commentator, i'll smash my head against the wall it necessary to crackdown, i never knew what it might mean for short term but so much of the media buys into this myth that america is a pitiful helpless giant and china is a

crouching tiger ready to rip their throats out. i'll say enough already. the trade war hurts them more than us. i've been amazed how little impact the tariffs are having an american consumers we know are spending more. i have lots of data since they are spending more than a year ago. i know this will get worse when the next round goes into effect in three weeks so far the price increase has been minimal they are trying to convince the president to back off the tariffs so they are making noises that price wills go up come september i hear them. i'm not sure i believe in them retail is so competitive, it's a viciously deflation environment for watch, walmart, amazon, target, home depot this business is flying into vietnam happening faster than the chinese government can

handle and forth conorth korea s to turn the jets on. this country needs to have people do what they need to do the president were to spend time in south korea and vietnam offering to help them compete against the chinese so they help us compete, it would help a lot. maybe you should have signed the partnership, the point was to unite different countries that excluded the chinese maybe you should create a collision. my broader point is we spent a lot of time obsessing over what could go wrong with the trade war and what could go right. maybe there is bias here i'm not talking about negotiations with china, they are going nowhere. what happens if president trump stops at this point. what if he has a golf match at bedminster the predatory trade practices affect most of the countries and frankly worse than ours. the sticking point is that the president wants to fix trade i'm balances at once so instead of tolerating, they dump cars here. he is confronting them and makes

it harder to assemble a collision. for the hand ring this trade war is doing damage to the chinese economy that lives or dies in the country's exports, not imports but not hurting us much at all let me throw one last example, we hear how china is going to devastate ag plenty of farmers are losing business i don't want to minimize what they are going through go look at the charts after getting hammered, they are both up substantially, i don't know, that shouldn't be happening. more importantly, if farmers get hurt, you know the federal government will bail them out. nobody ever lost their seat in congress by voting for a farm subsidy. so i don't want to hear any more defeating, you won't get any on this show. we get victory or a stalemate, we're worse off than before the tariffs. china changes ways and compromises with us and our stock market takes off perhaps sadly, without you let's go to kelly in texas,

please, kelly. >> caller: yes, jim, i was curious about the drilling rig in the basin and my question is about schlumberger. my question would be do we hold it for the dividend protection do we buy it at a discount or cut and run? >> my travel trust owns it i never thought i'd say this because i'm in love with the company since 1982 and looking to get a job there and schlumberger, these companies are not spending like they thought and the international countries aren't spending so the answer is i don't want you in my house of pain. it's just crowded enough already. let's go to stewart in maryland, stewart? >> caller: yeah, boo-yah, jim. long time watcher and first-time caller. >> all right. >> caller: what is your opinion of burlington stores ticker symbol --

>> i thank matthew boss for introducing me to the company. i think that the theory of retail now is either online or off price. you have to be one or the other. burlington is the king of off price. that's not just because of tom kings berry who is the ceo but out going. i think you buy burlington and buy it here. it's a perfect one to buy when you're looking what the is going on with retail i need to go to brian in michigan, please, brian. >> caller: hey, jim, thanks for taking my call. >> okay. >> caller: long time theeme thi. with the price near a 52-week low, what are your thoughts on the simon property group >> man, that's david simon he's good. i know that you're probably tempted to think they can't cover that dividend but i know that the malls are under stress. they have really good malls. i love to have david on. i think he will tell a very good story but i don't want to put words in his mouth because a lot of the retailers are 9% yield

now. that keeps going down. so let's do -- let's invite him on he's probably the best guy in that particular end of retail brick and mortar as american capital finds a way to beat capitalism, you're safe from u.s. stocks than you think. much more "mad" ahead. the whip saw action i'm eyeing one that should be up not down, then gw pharma is smoking hot. can it go higher let me talk to the ceo and a play for a cure, 100% in the last year. t tandum diabetes. stay with cramer when i was diagnosed with breast cancer,

i went straight to ctca. after my mastectomy, i felt like part of my identity was being taken away. my team made me feel whole again. cancer treatment centers of america. appointments available now.

turbulent market, you want to hide like drug companies but

with the industry unpopular, the group is less than a safe haven and that's not the on complicating factor. yesterday one of my favorites bosch health companies reported a mixed quarter and posted a small three cent earnings miss that's a very small business and we'll talk about that. slightly higher than expected sales is more important. it wasn't a perfect quarter, it was pretty solid bosch and lamb sold 4% organic growth and took a serious hit. management raised the full-year forecast and nobody seemed to care and the stock got hit which was otherwise a good day in the market they engineered a good turn but the stock stalled. what will get this thing back in action let's take a closer look with the chairman and ceo of bosch health companies to find out more about the quarter welcome back to "mad money". >> good to see you. >> you know i was confused i read anytime a vacuum.

i like to read the stories in a vacuum and look at the stock price. i don't like to be swayed by it. i thought the stock would be up a percent, 2%. huge organic growth much better than most, pay down debt, tell me what i'm missing. >> well, i don't think you're missing. you're got what was happening there. we labeled 2019 as the pivot to offense and that's what we've done we've had now six consecutive quarters of organic growth this quarter is up 3%. importantly as you mentioned, the biggest segments in the company are the bosch and lamb business, those two together represent 80% of my sales now. >> we used to say it was the fw

mercedes brands. >> bausch and lomb has a great reputation it's the leading product now in the area for the multi purpose solution the contact lenses, we had a situation in the united states where we are up for now 11 consecutive quarters in terms of growth and the bausch and lomb business is up 13% in the united states and market was only up 8% we're significantly out growing the market taking share and that's what we're excited about what it's working on. >> are you concerned by the subscription products sent to your house daily >> we think that that's something that we have to keep an eye on. >> don't you you don't want to get beaten by an e commerce player. >> absolutely. we're looking what is best for our programs and activity but we think it fund mentally comes down to a good product with good optics, comfort for the patient, we'll do well with the patients and that's happened and we have 11 consecutive quarters of growth there. >> also, in terms of your pivot,

i noticed the bump up in spending and the products, you brought, the rmd is working. >> it is when i joined three years ago, there is three things i have to do number one, we reduced the debt. number two, i'm going to invest in research and development and last quarter we were up 24% in research and development versus the previous year. clearly we're doing that and the third thing we have to do is launch products. over the last 18 months, we've launched more than nine key products so it's clearly going the right direction. i'm really pleased this is our product we just launched last month and it is doing outstanding. already, in just the first five weeks the product has been on the market it's generating 1700 prescriptions per week one of the fastest growing t topical products we see good things because it gives the promise of being able to treat patients until the skin

is clear rather than being limited for a certain duration of time. that's what we think is really exciting about it. >> i know this is -- for personal use got this. we typically use steroids but you're also told they thin the skin that's scary you have a before and after picture of what this did for someone and you ride it out. >> it's striking because it has the combination of a steroid that works to help the sopsoriasis. i was out working with the sells reps talking to doctors, they very much believe this is going to be a really important thing for any patient with psoriasis

we think this will be important. >> let's go back to the debt everyone is concerned because you don't have a dividend and buyback and they want that in a choppy market but you managed to make it until the debt pipemeayt schedule -- >> he's done a great job in reducing the quantity and moving the duration out because we don't have any real significant debt until 2023 and what that means is we have the ability to invest behind our products by investing them and get a good return and drive long-term shareholder value. >> tell me when you listened to the politicians talk. >> i think the pharmaceuticals in the end are going to be the reason why they are the most cost effective way to treat health and improve health. do i accept there will be some

white water rafting in terms of rapids yes. in the reality is long-term f m pharmaceuticals are the most cost effective for treating health i know there will be noise along the way. >> look, i think you're telling a compelling story and there is a lot of drug stocks that trade off the yield of 3%. that's not a lot of protection in this market with the rates as low as they are. i want growth. you're giving people growth. that's the chairman and ceo of ba usc h health. "mad money" is back after the break.sc h health. "mad money" is back after the break.sc h health. "mad money" is back after the break.usc h health "mad money" is back after the break.h health "mad money" is back after the break.

at comcast, we didn't build the nation's largest gig-speed network just to make businesses run faster. we built it to help them go beyond. because beyond risk... welcome to the neighborhood, guys. there is reward. ♪ ♪ beyond work and life... who else could he be? there is the moment. beyond technology... there is human ingenuity. ♪ ♪ every day, comcast business is helping businesses go beyond the expected, to do the extraordinary. take your business beyond.

they have businesses to grow customers to care for lives to get home to they use stamps.com print discounted postage for any letter any package any time right from your computer all the amazing services of the post office only cheaper get our special tv offer a 4-week trial plus postage and a digital scale go to stamps.com/tv and never go to the post office again!

cramer fav cap binnabis inse medicine it's real pharmaceuticals that can be dosed by real doctors because it's part of the same universe as the much more ske h sketchy weed companies this well-run drug company is punished even though it's not in the marijuana business last year they received the first and only approval for a formulation of plant derived cbd. that's the call, cbd their drug is a fabulous treatment for seizures and it turns out it's selling incredibly well. when they reported last night the company knocked it out of the mark and did $72 million in sales when wall street was looking for more that's the earnings of share barely to break even

no wonder the stock rocketed higher and surged more than 9% today. it's got more room to run. don't take it from me, let's dig deeper with justin, the ceo of gw pharmaceuticals and get a sense of the quarter and welcome back to "mad money." >> thank you, jim. thank you for having me back. >> you don't have a laugh, you're a very serious guy in a serious business but you're part of a cohort that has nothing to do with you. you're a major pharmaceutical company with a lot of goals. do you agree >> i do. what we can do, jim, is continue to deliver on the promise of the pipeli pipeline if you think when i was last on the show, we hit six months of revenue over $100 million in the first six months of 2019 over 12,000 patients receiving drug, over 2500 physicians by any

measure we're a company delivering and hopeful the market will appreciate that. >> the conference call is interesting. darron kline, you're u.s. chief financial officer, at one point says look, you're beginning learn the dosing it seems to me that the awareness is still in the infancy if that's what we're worried about and get much, much bigger than it is now. >> yeah, six months into this launch we're satisfied with the level of awareness but there is education to do explaining the medicine and how it works and the patients it can benefit. we're really at the beginning of this journey and given that we're six months in and the progress we've made, if i look forward six months from now or several years from now, there is so much roll fom for this produo go in the marketplace. >> why are you the only guy that has it we've had all the cannabis

companies on and nobody seems to be able to replicate what you do what's the secret sauce? >> this is not a product that emerged quickly. they are 20 years in the making and what it has required is real rigorous science, science around safety of cbd and certain patients, notwithstandi manufac that is simple and all of it takes time and so while we stand alone, we've earned the right to set ourselves apart from the pact because weaver been doing this for a long time and what we're offering to patients and physicians is quite distinct from other cannabis-based products this is a rigorously tested appropriately manufactured, fda approved pharmaceutical that patients can obtain through insurance coverage with all the hallmarks of a modern medication they would seek to take. >> if someone has a dull onset

of epilepsy, are they allowed to take your drug >> for patients that have epilepsy, there is easy access for those patients on insurance. physicians have discretion to be able to prescribe this medication within the field but of course, that is not for our company to promote and a judgment call for physicians to make in their own discretion i need to be cautious about how i describe the utilization of the drug but within the field of epilepsy, this is a first in class treatment and new approach with highly treatment resistant forms of epilepsy and it's clearly making its mark within the epilepsy field. >> i thought in your conference call, you're starting to talk more about side effects and that would do this is an ms drug that has a, i

would say, a much bigger total adjustable market, do you agree? >> well, the -- if we think about it and what it means as a historic first approval of fda approved cannabis medications, it's approved outside the field of m.s it makes clear sense for that to be the next priority for the company. we absolutely are turning our attention to it in the field of m.s. we're looking into psychiatric conditions, neurological conditions, as well. i think the world has really started to see they play a range of diseases with you are rolg. it is just the next in what we hope to be a series of pipeline programs coming to fda in the years ahead. >> that's incredibly exciting. it's important to point out that

it is not just cbd, it's also got thc. a lot of the legislators are scared of thc but it's valuable what it does with illnesses, isn't it >> yeah, it's thc and cbd and other plant components and mouth spray. it's carefully done to make sure we don't get thc-like highs in terms of the patient response. so the trick with thc is make sure the dosing is consistent and moderated in a way that you get some of the therapy benefits without the unwanted side effects and we think that's the formulation to achieve the goal. >> you're a breath of fresh air. alike a lot of cannabis executives but i like science, medicine, i like rigor you got them all the ceo of gw pharmaceuticals. thank you. >> thank you. >> this is not done. they have way too much in the

pipeline way too much exciting stocks out there. "mad money" is back after the "mad money" is back after the break. tell him we're flexible. don't worry. my dutch is ok. just ok? (in dutch) tell him we merger. (in dutch) it's happening..! just ok is not ok. especially when it comes to your network. at&t is america's best wireless network according to america's biggest test. now with 5g evolution. the first step to 5g. more for your thing. that's our thing.

it is time, it is time for the lightening round buy, buy, buy, sell, sell, sell, sell, buy, buy. >> then the lightning round is over are you ready ski daddy? time for the lightning round i'll go with fiona in california. >> caller: hi, this is fiona's mom tracy, i want to introduce you to fioana and isabella they are 12. >> caller: hi, cramer. >> i thought the chirp didn't like about it. >> i'm 12 years old and our brothers are big gamers and we want to know if we should invest babysitting or dog walking in activism before it reports tomorrow. >> i love kids babysitting and dog walking money. how come i don't get money walking the dog? we'll be in take two interactive. a better portfolio and that's

the one you remember grand theft auto and nba 2 k and that's where we're going okay, we're going to adrian now in massachusetts, adrian >> caller: hello, hi, jim, how are you? >> good. how are you? >> caller: good. i wanted to ask about pvtl i bought it after the last earnings announcement and it continued to go down the whole time is it a hold or sell >> i don't, you know, this is down almost 50%. actually, the chairman is actually pretty good you got to wait for a bounce i can't just tell you to get rid of it here that's just too much let's wait a bit but then you got to go. there is nothing there let's go to bill in pennsylvania, bill >> caller: hey, jim, biggest boo-yah from pittsburgh, p.a. with the recent pivot to more solutions based products and a 20% drop all-time high is emmerson electric a buy?

>> kind of down beat conference call not that quarter, not that bad 3.2% doesn't cover it really bad in terms of growth in china. i'm going to say we take a pass until it gets to 3.5 let's go to gary in connecticut, gary. >> caller: hey, jim, how are you? ten years ago i purchased barns group stock for $14 a share and this year i shot up to 72 closed today at 45. what is your opinion of the company -- >> it's a bread and butter manufacturing company with a lot of air space and i mentioned i didn't like it it's hard to say buy barns if i thought emmerson would go lower. this could go lower still before it finds a bottom. maggie in ohio, maggie >> caller: hi, jim, i've been with you since your radio show. >> wow old as the hills what's up? >> caller: i know. well, i was very young at the time. >> you and me both, partner.

>> caller: i don't know what to do with sales force. i mean -- >> no, no, come on, we know what to do. begin to buy more. it's above the basis for the actionalertsplus.com club. keep on and that would be a big save dream force coming up and what more could i say i want to go to liberty in illino illinois. >> caller: dr. cramer, this is chris in illinois. from one professor to another one, boo-yah >> caller: give me liberty and give me hasbro a second class hasbor and that ladies and gentlemen, is the conclusion of the lightning round. >> announcer: the lightning roun

round is sponsored by td ameritrade ♪♪ ameritrade (soft music) - when i see obstacles, i create opportunities. - when i see adversity, i find a way. - when i hear never, i say now. - [announcer] southern new hampshire university is education made to fit your goals with over 200 degree programs, flexible class schedules, and some of the lowest online tuition rates in the nation. (cheering) - so when i face barriers, i can break through. - [announcer] breakthrough at snhu.edu.

in a difficult moment, i want to keep circling back to the stocks of high quality companies we know are in great shape because they just reported excellent numbers. companies like diabetes care and combine their product with the continuous glucose monitor like the kind we talk about, it has been a good stock it's like

having a pancreas. it's been an incredible long-term performer and the last time we spoke in early march, the stock rallied 2,000% over the previous year. that's right just over the course of january and february, the darn thing doubled. i was worried it might need to take time to cool off after such an epic move and sure enough, the stock spent the last few months trading in a pretty tight range. it's down $15 from highs in march and pulled back it's looking pretty attractive. especially since tndm reported a fabulous quarter, i noticed thanks to the market meltdown. sales up 173% year over year in response to stocks popping 8% on friday but giving back every penny and then some thanks to the sell off in other words, you can get unbelievable blowout quarter for free let's check in with kim.

welcome back to "mad money." >> thanks for having me. >> analysts were dazzled probably the greatest beat ever. they were going nuts do you think what happened if you talk about stocks, that's all me was a muted response in terms of the stocks, would that be your company stock had an incredible run, everybody knows how great the company is doing >> well, i would say in your opening comments you sort of had it correct, there was so much global uncertainty in this earnings period and disney missed, as well. so i think there is just some investor sort of hesitation now. people are wondering when we're headed into a recession. we don't sell in china and make in china fundamentals are in tact and in fact, year of year sales rates in q 2 accelerated from q 1 1. we're in an acceleration mode

and people don't appreciate that. >> i searched for reasons and started thinking is it possible that demand is too great and you can't meet it? >> oh, absolutely not. that is probably the only thing under our control that could disrupt this growth, and we've been looking at this, we've been looking at internal projections and we have a very, very solid manufacturing team prepared for the demand and we have, you know, ranges of volume that we think we need to get to to stay on track and handle all this growth. >> a lot of talk where people built manufacturing. i saw you put it in boise. could you have done it in china because of the regime in washington >> i was going to boise is a customer support group that's very attractive area. we want to build within the time zones where we serve customers, so that's not manufacturing. the manufacturing is here in san

diego. we could go to china but haven't. we need to control product quality that's important there is a unique device and we need to have manufacturing near our development engineers so there is proper coordination and good focus on quality. so that's why it's here. >> so you think that it's possible that if you want great quality, you have to make it in america? >> that's the way i feel about this particular product, absolutely this is not a cookie cutter generic product. it's very complex in the engineering changes constantly as we make improvements. >> so tell me how you get accelerated revenue. is that because the partnership with dexcom. i don't feel people know you do indeed have the best mouse trap. >> yeah, we talked about this last time only about 30% of type run diabetics are using a pump so we are going to expand that market we're actually calling those multiple daily injectors coming

over to a pump that was a big part of our growth and part of that dynamic was having the g 6 with no finger sticks combined with basil iq the product is simpler, far more effective and makes insulin safe and expanding mat marrketplace. we released clinical trial results at ada, control iq i've never seen a crowd that big in my career here. the awareness in the medical community was broad and wide spread and we didn't have that with basil iq. basil iq surprised us and i think control iq will, as well. >> that's for people, the american diabetes association rather remarkable presentation study. 30% of the 1.6 billion people with type one in the united states, i was listening to miles white from abbot the actual worldwide population is gigantic and a monster unfortunate problem. >> yes, it is and the type one

part of this marketplace is also big worldwide. i think it may be type two or maybe combinations but we're finding that in europe it's a very significant market for us and we are, you know, gaining traction in that market, as well that's a driver of our off skpi sid and revised guidance. >> one last question, when you look at these studies that you're doing, i'm trying to figu figure out when you offer pivotal data, what's the time period from pivotal data to when it's in the market >> well, it's the fda gaining time frame and we're predicting we'll have approval this year and then traditionally, how quickly could you launch that product? normally it was a new hardware upgrade with us as a software upgrade so our launch would be almost instantaneous that's one of the advantages of our device update we were

talking about. >> terrific. this is a terrible epidemic and you have something that really does work. thank you to tandem diabetes good to see you, sir. >> good to see you. >> this may with a situation where the stock is its own worst enemy up so, so much that even when they blow out the numbers, nobody cares but you know they will care again soon stick with cramer.

in last night's fabulous show and thanks to the crew for making it look and feel great, i mentioned you have to biuy samantic and this is a fantastic situation. tonight, press reports that there might be a deal with br d broadcom buy it for 23.5. on an earnings basis, i feel ache what rick hill is doing warrants 23.5. i like to say there is always a bull market somewhere. i promise the help you find it somewhere. i'm jim cramer, i'll see you tomorrow [upbeat music]

male announcer: inside one of these 26 cases... ♪ is one chance... ♪ at $1,000,000. tonight, it's the ultimate stand-off. - i love that the banker's a woman. - we'll see if you still say that by the end of the game. announcer: the "deal or no deal" banker faces a wall street lifer. - she wants to know who she's up against. - i am lady trader. i've done it since i'm 18 years old. announcer: but in a volatile market... - ooh. - oh! [cheers and applause] - no deal! - this game has been the biggest roller coaster